Oncology

Studies present results from a real-life observational study in Ireland demonstrating significant reductions in chemotherapy and resulting cost-savings when the test is used in early stage breast cancer.

Lugano, 25 February 2015 – Within the “umbrella” of rare diseases, rare cancer patients confront particular problems. Most rare diseases have an…

BREAST cancer patients with small node-negative HER2-positive tumours achieved 3-year survival approaching 100% with adjuvant paclitaxel and trastuzumab…

PROGRAMMABLE biomaterial that is capable of spontaneously assembling into a fighting structure once injected into a living body has the potential to…

A brand new year is at our fingertips and with it comes a new opportunity to explore additional avenues regarding the issue of men’s health awareness.

GENEVA, Switzerland, [December 15, 2014] – Genomic Health announced presentation of the first prospective outcomes data from a large adjuvant study…

San Francisco, December 10, 2014 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced long-term follow-up results from the registration studies…

Lugano/Geneva, Switzerland, 24 November 2014 – High-dose interleukin-2 can be effective in selected metastatic renal cell cancer patients pre-treated…